NYSE · Consumer products

Colgate-Palmolive Co

Q: Is CL stock a good investment?

Colgate-Palmolive is typically valued as a defensive consumer staples holding — a company whose products sell reliably regardless of economic conditions. Its consistent margins and dividend history attract investors seeking stability. That said, the stock often trades at a premium valuation relative to earnings growth, meaning slower top-line expansion can limit upside. Private-label competition, raw material cost volatility, and currency fluctuations in emerging markets are the primary risks for long-term holders.

Q: Who are Colgate-Palmolive Co's main competitors?

Procter & Gamble is the most formidable rival, competing in oral care with Crest and Oral-B and across personal care broadly. Unilever challenges Colgate in soap, home care, and international markets. Church & Dwight competes in oral and personal care with brands like Arm & Hammer. In pet nutrition, Hill's competes directly with Purina (Nestlé) and Royal Canin for the premium veterinary segment.

Q: What is the current share price of CL?

CL is currently trading at $85.49, up 1.14% in today's session. Over the past 52 weeks, the stock has traded between a low of $74.55 and a high of $100.18. The current price represents 43% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: Is CL rated a buy or sell by analysts?

Among 30 analysts covering CL, the consensus rating is Buy — 19 rate it a buy, 10 hold, and 1 sell. The average price target sits at $201.99, implying 136% upside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: What are Colgate-Palmolive Co's earnings?

Colgate-Palmolive Co generated $20.14B in revenue during fiscal year 2026, with $2.11B reaching the bottom line as net income. The net profit margin of 10.5% is solid for its sector.

Q: How is CL valued compared to earnings?

CL trades at a P/E ratio of 35.19 on trailing earnings of $2.62 per share. That's above the S&P 500 historical average, suggesting the market expects above-average earnings growth ahead. Comparing this multiple against Consumer products sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

S&P 500 Large-Cap Stocks Blue Chip Stocks Best Dividend Stocks

$85.49

+0.96 (+1.14%)

Day Range $83.95 — $85.51

52W Range $74.55 — $100.18

Performance

1D —

1W —

1M —

3M +7.22%

6M +6.33%

1Y -7.11%

YTD +10.04%

Open$85.25

Previous Close$84.53

Day High$85.51

Day Low$83.95

52W High$100.18

52W Low$74.55

Volume—

Avg Volume6.15M

Market Cap74.99B

P/E Ratio35.19

EPS$2.62

SectorConsumer products

Technical Indicators

Full analysis →

SMA 50 $84.63 Above

SMA 200 $84.48 Above

RSI (14) 77.2 Overbought

Trend Golden Cross Bullish

Analyst Ratings

Buy

30 analysts

19 Buy 10 Hold 1 Sell

Price Target +136.3% upside

Current
$85.49

Target
$201.99

$139.01 $201.99 avg $291.63

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	20.14B	19.31B	17.34B
Net Income	2.11B	1.82B	3.05B
Profit Margin	10.5%	9.9%	17.6%
EBITDA	3.27B	2.98B	3.66B
Free Cash Flow	—	—	1.32B
Rev Growth	+4.3%	+4.3%	+19.7%
Debt/Equity	147.93	147.93	0.87

Dividend

Dividend Yield2.24%

Annual Dividend$2.26

Payout Ratio85.5%

Frequencyquarterly

Ex-Dividend—

Pay Date—

Recent Insider Activity

All Insiders →

Date	Insider	Type	Shares	Price	Value
Feb 13	Tsourapas Panagiotis	Exercise	45,415	$76.41	$3.47M
Feb 13	Tsourapas Panagiotis	Sale	10,415	$94.61	$985.4K
Feb 13	Tsourapas Panagiotis	Exercise	34,938	$0.00	—
Feb 13	Tsourapas Panagiotis	Exercise	25,415	$76.41	$1.94M
Feb 13	Tsourapas Panagiotis	Sale	10,415	$97.81	$1.02M

About Colgate-Palmolive Co

Colgate-Palmolive Company is a global consumer products company that manufactures and markets oral care, personal care, home care, and pet nutrition products, headquartered in New York City. The company's portfolio includes leading brands such as Colgate toothpaste, Palmolive, Softsoap, Irish Spring, and Hill's Pet Nutrition. Colgate-Palmolive is the world's leading oral care company by market share. The company sells products in over 200 countries and territories through retail, wholesale, and e-commerce channels, with particularly strong positions in emerging markets.

Consumer products Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
PG	Procter & Gamble Co	$143.92	+0.53%	22.4	368.49B
DHI	Dr Horton Inc	$137.69	-0.46%	14.2	47.45B
GRMN	Garmin Ltd	$244.78	+1.52%	29.1	45.76B
EL	Estee Lauder Companies-Cl A	$73.11	+2.28%	—	30.87B
KVUE	Kenvue Inc	$17.66	+0.63%	22.7	33.41B
KMB	Kimberly-Clark Corp	$99.36	+0.44%	16.1	32.59B

CL Frequently Asked Questions

What does Colgate-Palmolive Co do?

Colgate-Palmolive makes money by selling everyday consumer staples that people repurchase habitually — toothpaste, toothbrushes, bar soap, dish liquid, and pet food. The Colgate brand holds the top global market share in toothpaste, giving it outsized pricing power in a category where brand trust drives repeat buying. Hill's Pet Nutrition has become a significant growth engine, targeting the premium veterinary and specialty pet food market. Emerging markets in Latin America, Asia, and Africa account for a substantial share of revenue and growth.

Is CL stock a good investment?

Colgate-Palmolive is typically valued as a defensive consumer staples holding — a company whose products sell reliably regardless of economic conditions. Its consistent margins and dividend history attract investors seeking stability. That said, the stock often trades at a premium valuation relative to earnings growth, meaning slower top-line expansion can limit upside. Private-label competition, raw material cost volatility, and currency fluctuations in emerging markets are the primary risks for long-term holders.

Who are Colgate-Palmolive Co's main competitors?

Procter & Gamble is the most formidable rival, competing in oral care with Crest and Oral-B and across personal care broadly. Unilever challenges Colgate in soap, home care, and international markets. Church & Dwight competes in oral and personal care with brands like Arm & Hammer. In pet nutrition, Hill's competes directly with Purina (Nestlé) and Royal Canin for the premium veterinary segment.

Does Colgate-Palmolive Co pay dividends?

Colgate-Palmolive has paid a dividend continuously for well over a century and is considered a Dividend King — having raised its payout for more than 60 consecutive years. The company prioritizes returning cash to shareholders through both dividends and share buybacks. Its dividend yield sits in a moderate range typical of stable consumer staples companies, with increases generally tracking earnings growth rather than large step-ups.

What is the current share price of CL?

CL is currently trading at $85.49, up 1.14% in today's session. Over the past 52 weeks, the stock has traded between a low of $74.55 and a high of $100.18. The current price represents 43% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Is CL rated a buy or sell by analysts?

Among 30 analysts covering CL, the consensus rating is Buy — 19 rate it a buy, 10 hold, and 1 sell. The average price target sits at $201.99, implying 136% upside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

What are Colgate-Palmolive Co's earnings?

Colgate-Palmolive Co generated $20.14B in revenue during fiscal year 2026, with $2.11B reaching the bottom line as net income. The net profit margin of 10.5% is solid for its sector.

How is CL valued compared to earnings?

CL trades at a P/E ratio of 35.19 on trailing earnings of $2.62 per share. That's above the S&P 500 historical average, suggesting the market expects above-average earnings growth ahead. Comparing this multiple against Consumer products sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

What is CL's return over the past year?

Performance varies across timeframes, reflecting shifting market conditions. Returns by timeframe: +7.22% (3M), +6.33% (6M), -7.11% (1Y), +10.04% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether CL is outperforming or lagging the broader market.